Wilkins Investment Counsel’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $406K | Hold |
6,700
| – | – | 0.06% | 98 |
|
|
2025
Q4 | $361K | Hold |
6,700
| – | – | 0.05% | 103 |
|
|
2025
Q3 | $302K | Hold |
6,700
| – | – | 0.04% | 110 |
|
|
2025
Q2 | $310K | Hold |
6,700
| – | – | 0.04% | 111 |
|
|
2025
Q1 | $409K | Sell |
6,700
-866
| -11% | -$50.5K | 0.06% | 101 |
|
|
2024
Q4 | $428K | Sell |
7,566
-53
| -0.7% | -$2.96K | 0.06% | 104 |
|
|
2024
Q3 | $394K | Buy |
7,619
+53
| +0.7% | +$2.49K | 0.05% | 108 |
|
|
2024
Q2 | $314K | Hold |
7,566
| – | – | 0.05% | 112 |
|
|
2024
Q1 | $410K | Buy |
+7,566
| New | +$385K | 0.06% | 105 |
|
|
2023
Q1 | – | Sell |
-2,800
| Closed | -$201K | – | 75 |
|
|
2022
Q4 | $201K | Buy |
+2,800
| New | +$211K | 0.05% | 76 |
|
|
2022
Q3 | – | Sell |
-2,800
| Closed | -$216K | – | 75 |
|
|
2022
Q2 | $216K | Hold |
2,800
| – | – | 0.06% | 75 |
|
|
2022
Q1 | $204K | Buy |
+2,800
| New | +$188K | 0.05% | 78 |
|
|
2020
Q1 | – | Sell |
-3,479
| Closed | -$223K | – | 71 |
|
|
2019
Q4 | $223K | Buy |
+3,479
| New | +$199K | 0.06% | 74 |
|
|
2018
Q4 | – | Sell |
-3,754
| Closed | -$233K | – | 75 |
|
|
2018
Q3 | $233K | Hold |
3,754
| – | – | 0.07% | 75 |
|
|
2018
Q2 | $208K | Hold |
3,754
| – | – | 0.07% | 74 |
|
|
2018
Q1 | $237K | Hold |
3,754
| – | – | 0.08% | 74 |
|
|
2017
Q4 | $230K | Sell |
3,754
-507
| -12% | -$31.7K | 0.07% | 75 |
|
|
2017
Q3 | $272K | Buy |
4,261
+244
| +6% | +$14.2K | 0.08% | 72 |
|
|
2017
Q2 | $224K | Sell |
4,017
-300
| -7% | -$16.3K | 0.07% | 75 |
|
|
2017
Q1 | $235K | Hold |
4,317
| – | – | 0.08% | 74 |
|
|
2016
Q4 | $252K | Sell |
4,317
-50
| -1% | -$2.73K | 0.08% | 73 |
|
|
2016
Q3 | $235K | Sell |
4,367
-1,500
| -26% | -$96.4K | 0.08% | 74 |
|
|
2016
Q2 | $432K | Buy |
5,867
+50
| +0.9% | +$3.53K | 0.15% | 66 |
|
|
2016
Q1 | $372K | Buy |
5,817
+1,565
| +37% | +$98.7K | 0.14% | 68 |
|
|
2015
Q4 | $292K | Sell |
4,252
-1,400
| -25% | -$92.5K | 0.11% | 73 |
|
|
2015
Q3 | $335K | Buy |
5,652
+275
| +5% | +$17.4K | 0.13% | 71 |
|
|
2015
Q2 | $358K | Hold |
5,377
| – | – | 0.13% | 70 |
|
|
2015
Q1 | $347K | Hold |
5,377
| – | – | 0.12% | 71 |
|
|
2014
Q4 | $317K | Hold |
5,377
| – | – | 0.11% | 73 |
|
|
2014
Q3 | $275K | Hold |
5,377
| – | – | 0.1% | 75 |
|
|
2014
Q2 | $261K | Hold |
5,377
| – | – | 0.09% | 77 |
|
|
2014
Q1 | $279K | Sell |
5,377
-400
| -7% | -$21.3K | 0.1% | 73 |
|
|
2013
Q4 | $307K | Hold |
5,777
| – | – | 0.13% | 57 |
|
|
2013
Q3 | $267K | Hold |
5,777
| – | – | 0.12% | 57 |
|
|
2013
Q2 | $258K | Buy |
+5,777
| New | +$251K | 0.12% | 59 |
|
Other funds holding BMY
VCM
VPM
Wilkins Investment Counsel's BMY Position: Q1 2026 in Review
Wilkins Investment Counsel held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 6,700 shares worth $406K. The position accounts for 0.06% of the portfolio, ranked #98.
Wilkins Investment Counsel first reported a position in BMY in Q2 2013 and has held it in 35 quarters since. The position peaked at $432K in Q2 2016. 2,521 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Wilkins Investment Counsel held 6,700 shares of Bristol-Myers Squibb worth $406K as of Q1 2026.
- Wilkins Investment Counsel left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 0.06% of Wilkins Investment Counsel's portfolio in Q1 2026, its #98 holding.
- Wilkins Investment Counsel first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 35 quarters since.
- Wilkins Investment Counsel's Bristol-Myers Squibb position peaked at $432K in Q2 2016.
- 2,521 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Wilkins Investment Counsel's 13F filing for Q1 2026, filed 7 May 2026.